Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension

• Príomhchruthaitheoirí: Macarena Orejudo (Údar), Raul R. Rodrigues-Diez (Údar), Raquel Rodrigues-Diez (Údar), Ana Garcia-Redondo (Údar), Laura Santos-Sánchez (Údar), Javier Rández-Garbayo (Údar), Pablo Cannata-Ortiz (Údar), Adrian M. Ramos (Údar), Alberto Ortiz (Údar), Rafael Selgas (Údar), Sergio Mezzano (Údar), Carolina Lavoz (Údar), Marta Ruiz-Ortega (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Frontiers Media S.A., 2019-09-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Hypertension is now considered as an inflammatory disease, and the kidney is a key end-organ target. Experimental and clinical studies suggest that interleukin 17A (IL-17A) is a promising therapeutic target in immune and chronic inflammatory diseases, including hypertension and kidney disease. Eleva...